Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001209191-17-023142

10% owner bought 12,870,000 shares at $0.70 ($9,009,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BARRETT M JAMES 10% owner 2017-03-27 Purchase +12,870,000 $0.70 $9,009,000 72,139,000 I
Open-market purchases · 12,870,000 sh · avg $0.70 · $9,009,000
Loading xslF345X03/doc4.xml…